anonymous
Guest
anonymous
Guest
B.s, right hereTad is the biggest fake Pharma has ever produced….and that’s saying something. Keep saying transparency though
B.s, right hereTad is the biggest fake Pharma has ever produced….and that’s saying something. Keep saying transparency though
MoronActually it’s #TRUTH. Probably has a Bernie Sanders sticker on the bumper of his Prius too. He has no business leading this division. He commands zero respect from the salesforce. Morale is at an all time low. Almost like he forgot what it’s like to carry the bag. If he even has. And if he did he definitely wasnt a performer. He’s all over us about target reach yet target reach isnt even updated in powerbi. Now we’re going to excel spreadsheets like it’s 1999. Whats next, TPS reports??? Get it together man. Listen to your people. We are the boots on the ground. We know whats best for our business.
Agreed, the spreadsheet thing made me literally laugh out loud.Actually its #TRUTH. Probably has a Bernie Sanders sticker on the bumper of his Prius too. He has no business leading this division. He commands zero respect from the salesforce. Morale is at an all time low. Almost like he forgot what it’s like to carry the bag. If he even has. And if he did he definitely wasnt a performer. He’s all over us about target reach yet target reach isnt even updated in powerbi. Now were going to excel spreadsheets like it’s 1999. Whats next, TPS reports??? Get it together man. Listen to your people. We are the boots on the ground. We know whats best for our business.
Because the oncology rep was competent and made a move to sell Tepezza. They make probably 80-100k more.Why is an oncology rep calling on ophthalmologists?
LMAO no, nice try idiot that’s not what was asked. Oncology isn’t selling Tepezza, they are promoting the Eylea biosimilar. Why it was given to oncology is beyond me.Because the oncology rep was competent and made a move to sell Tepezza. They make probably 80-100k more.
Hit the nail right on the head. We are 2 weeks in and already mgmt is freaking out, a report was sent with those SAMs who don’t have any PEFs yet and were asked for justification as to why.I can assure you that next year will be metrics driven. Number of calls. Calls on targets as prescribed by ZS. No patience for variance with over calling on targets. Number or programs. Number of emails. Number of opened and resolved rep alerts. Time to open alert. Things you can't even imagine. Amgen knows no other way. There is zero sales culture. There is only the culture of measurement for measurements sake. Buckle up.
100%Hit the nail right on the head. We are 2 weeks in and already mgmt is freaking out, a report was sent with those SAMs who don’t have any PEFs yet and were asked for justification as to why.
Many managers have relayed that this year will be all about metrics… at least one program a qtr is required, and it’s only going to get more intense as the year goes on.
Management feels that there are far more patients out there than are being diagnosed. Tad wants to treat TED like dry eye. Buckle up!
None of that matters. TED market is about to get crowded very soon. When is the Tepezza sub cue coming?!?Regardless of the GM spread across Amgen's commercial business, they only know one thing: Reach and Frequency. Make 2 more calls per day on the recipe ZS gives us. That's it.
You are full of shitHit the nail right on the head. We are 2 weeks in and already mgmt is freaking out, a report was sent with those SAMs who don’t have any PEFs yet and were asked for justification as to why.
Many managers have relayed that this year will be all about metrics… at least one program a qtr is required, and it’s only going to get more intense as the year goes on.
Management feels that there are far more patients out there than are being diagnosed. Tad wants to treat TED like dry eye. Buckle up!
Why?Y
You are full of shit
I make 400k last year, 2024 so not sure who you’re referring toNothing wrong with this. Is actually easier. Just show up a few times and fake the rest of the calls.
The problem is that Amgen doesn't pay well. I know reps on the Tepezza team that used to make 300k a year in bonuses. Now its a 250k a year total job. Not bad, but not what we are used to.